BiotechTube
Data
Discover
News
Company
Search...
⌘K
Sign in
BiotechTube
Home
/
Axelia Oncology
/
Ardian Latifi, PhD
AL
Ardian Latifi, PhD
Director, Clinical Operations
Axelia Oncology
Therapeutic Areas
Oncology
Immunology
Axelia Oncology Pipeline
Drug
Indication
Phase
AXA-042
Solid Tumors (checkpoint‑insensitive)
Phase 1
Leadership Team at Axelia Oncology
AG
Anna Galkin, PhD
Chief Scientific Officer
View full Axelia Oncology profile